Daniel Deguisto
Acute Care · Philadelphia, PANPI 1659045839
Payments from drug & device makers
Across 12 payments — averaging $22.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$46
- Amgen$45
- Actelion Pharmaceuticals US, Inc.$40
- Daiichi Sankyo Inc.$25
- Scpharmaceuticals Inc.$23
- Sandoz$22
- plus $65 from 4 others
What the payments were for
- Food & beverage$265100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 1 | $46 |
| Amgen | 2 | $45 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Sandoz | 1 | $22 |
| Sobi, Inc | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $15 |
| AstraZeneca | 1 | $14 |
How this compares
$265 in reported general payments places this provider in the 50th percentile of 872 acute care providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 17 | $11,283 |
| Oxycodone Hcl | 248 | $5,950 |
| Buprenorphine | 16 | $4,389 |
| Fentanyl | 34 | $2,318 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 42 | $1,696 |
| Morphine Sulfate ErMorphine Sulfate | 58 | $1,035 |
| Pregabalin | 66 | $939 |
| Duloxetine Hcl | 24 | $916 |
| Gabapentin | 29 | $828 |
| Morphine Sulfate | 20 | $674 |
| Hydromorphone Hcl | 34 | $626 |
| Celecoxib | 11 | $625 |
| Famotidine | 20 | $573 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $540 |
| Mirtazapine | 33 | $512 |
Paid to pharmacies, not to this prescriber.
Other acute care in Philadelphia
- Kathryn GreenPhiladelphia$92K
- Caroline PratzPhiladelphia$77K
- Rebecca MarcantuonoPhiladelphia$17K
- Stephanie TothPhiladelphia$17K
- David JonesPhiladelphia$11K
- Colleen KollerPhiladelphia$11K
- Maura LevandowskiPhiladelphia$9K
- Christopher SipalaPhiladelphia$9K
- Amaryah YaegerPhiladelphia$7K
- Shane RudolphPhiladelphia$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.